MedVi vs RxActivate: Pricing, process, and medication differences
Quick verdict: MedVi is clearer on first-month pricing and offers a no-clinic, clinically dosed compounded semaglutide path starting at $179/month; RxActivate requires a gated intake and contact step before revealing any plan or price, so it is better for those who want clinician-matched options before seeing costs.
Start MedVi intake and see the $179 promo
MedVi vs RxActivate at a glance
This comparison focuses on the most distinctive differences between MedVi and RxActivate: pricing transparency and promotional starts, whether medications are compounded and disclosed, the enrollment and eligibility flow, ongoing support and shipping disclosure, and regulatory notes about compounded drugs. The primary keyword MedVi vs RxActivate appears throughout to help readers evaluate these contrasts.
Distinctive differences summarized
| Criteria | MedVi | RxActivate |
|---|---|---|
| Starting price shown | Starting at $179 for first month (winter promo) including fast, free shipping | Unverified; pricing gated behind medical intake and contact information |
| Medication type disclosed | Clinically dosed compounded semaglutide (compounded meds not FDA-approved) | Clinician-matched GLP-1 plans; compounded medications, when offered, are not FDA-approved |
| Enrollment flow | Simple online intake, no clinic visits; clinician review after intake | Two-minute eligibility questionnaire; requires name, email, phone before pricing |
| Support and access | 24/7 support from certified medical professionals claimed on landing page | State and medical-safety screening; Alabama confirmed serviceable in synthetic test |
| Shipping and fees visibility | Fast, free shipping for promo month; refill pricing noted to rise after promo | No shipping, membership, or medication fees disclosed before contact-information gate |
Pricing transparency and promotional structure
MedVi displays a winter promotional first-month price of $179 that explicitly includes fast, free shipping and notes the ongoing monthly price rises afterward. The platform documents a standalone month at $299 and a three-month plan at $649 as post-promo options. In contrast, RxActivate does not show any price or billing terms before the contact-information step; pricing is gated behind the eligibility questionnaire and submission of name, email and phone number. This makes MedVi more transparent up front, while RxActivate requires completing intake to learn costs.
Begin RxActivate eligibility quiz
Compounded medications, ingredients, and regulatory notes
Both providers reference compounded options in their captured evidence. MedVi advertises clinically dosed compounded semaglutide and explicitly states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. RxActivate notes that compounded medications, when offered, are not FDA-approved and cautions that medication-specific approval status must be confirmed. Neither source provides FDA approval claims for compounded products; those regulatory qualifiers are preserved exactly.
Enrollment flow and clinician review
MedVi’s process is a simple online intake with no clinic visits and an online clinician review; OpenLoop Health clinicians review eligibility after checkout and retain prescribing discretion. RxActivate uses a two-minute eligibility questionnaire that requests goals, medication history, demographics, and a safety screen. In the synthetic test, RxActivate confirmed Alabama serviceability but required contact information before revealing likely plan details or pricing. If you prefer to see price and shipping terms immediately, MedVi is explicit. If you prefer being matched by a clinician before seeing cost, RxActivate enforces that sequence.
Support, shipping, and outcome claims
MedVi emphasizes 24/7 support from certified medical professionals and includes fast, free shipping for the promotional month. The MedVi evidence includes self-reported patient outcomes and states results may vary, with several qualifiers about program adherence and clinician discretion. RxActivate’s captured content highlights state and medical-safety screening and does not disclose support hours or shipping terms before lead capture. Outcome claims on both platforms are provider-published and not independent evidence in the captured material.
Check eligibility and clinician-match
How to choose: final guidance for MedVi vs RxActivate
Choose MedVi if you want a clearly advertised promotional first month starting at $179, no clinic visits, clinically dosed compounded semaglutide, and 24/7 certified medical support with fast, free shipping for the promo period. Choose RxActivate if you prefer a clinician-matched plan and are willing to complete the eligibility flow and provide contact information before seeing pricing, fees, or shipping details. Both note that compounded medications are not FDA-approved and that clinician review determines eligibility and prescribing.
Primary keyword reminder: MedVi vs RxActivate is a choice between upfront pricing and a gated clinician-match flow; use the provider that fits whether you value immediate price transparency or clinician-first eligibility screening.